Not all skincare tools are the same. Here is why FDA clearance and clinical data matter for your skin health.
Johnson & Johnson (NYSE:JNJ) reported 48-week results from its Phase 3 FUZION study evaluating Tremfya (guselkumab) in adults with Crohn’s disease and active perianal fistulas, showing that fistula ...
Most people have never given much thought to how long they can stand on one foot. It feels trivial, almost childlike. Yet ...
Can one "bad apple" spoil a bushel? A single flawed study influenced clinical guidance for prescribing Prozac for childhood ...
Dementia mortality risk varies by neighborhood, peaking in many suburbs due to socioeconomic, healthcare access, and ...
A benchmark study combining adaptive background modeling, four-frame differencing and occlusion-aware tracking reached 92.9% ...
Resmed (NYSE: RMD, ASX: RMD), the leading health technology company focused on sleep, breathing and care delivered in the home, today announced the U.S. launch of AirTouch F40, the newest addition to ...
Researchers analyzing health records from 62.5 million people in England found that the prevalence of 406 rare diseases ...
PsyPost on MSN
People with darker personalities tend to prefer partners like themselves, study suggests
People generally want a romantic partner who is kind and cooperative, yet some individuals are drawn to manipulative ...
A WashU Medicine project is developing a treatment to reverse tissue damage in osteoarthritis, a leading cause of disability.
QuantumCyte’s AI-guided platform prints polymers over healthy cells in biopsies, enriching tumor DNA purity to identify ...
Blakeman and Hochul have both billed themselves as candidates with the unique ability to appeal outside their base.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results